ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 693867 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 693867; 2) Community: the network communities that were significantly associated with the response to NSC 693867; 3) Molecule: the relationships between components within communities and NSC 693867; 4) MDR: the compounds that were significantly associated with the NSC 693867.

NSC Compound Enrichment Correlation
NSC 756401 GW832467X 0.022188614181866 -0.071976246
NSC 92207 Null 0.022188614181866 0.44609673
NSC 9594 Safranin bluish 0.022188614181866 0.35939772
NSC 702045 2-Propenone, 1,1'-(2,5-pyridinediyl)bis[3-(3,4-dimethoxyphenyl)- 0.0235234559682125 0.55607516
NSC 716679 Null 0.0235234559682125 0.53471011
NSC 724784 (1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.0 0.0235234559682125 0.55156294
NSC 750970 3-[(E)-1-(3-1-[(4-fluorophenyl)sulfonyl]-4-piperidylimidazo[1,5-a]pyridin-1-yl)methylidene]-2-indolinone 0.0235234559682125 -0.30141731
NSC 763587 Null 0.0235234559682125 0.51015472
NSC 13479 Null 0.0235234559682128 0.034589752
NSC 174121 Methotrexate Derivative 0.0235234559682128 0.43175317
Total:138  Current:79    [First] [Prev] [Next] [Last]